Literature DB >> 22589643

Pre-eclampsia: is it all in the placenta?

Harbindar Jeet Singh1.   

Abstract

Hypertensive disorders of pregnancy complicate almost 7 - 10 % of all pregnancies. The dyad of hypertension and proteinuria after 20 weeks of gestation is referred to as pre-eclampsia. It is a major cause of maternal morbidity and mortality and is also associated with increased perinatal problems. Despite intensive research over the years the exact cause of pre-eclampsia remains unknown. Nevertheless, information gleaned from published studies point to the placenta as the probable pathogenetic focus of pre-eclampsia, as the disease usually resolves within 24 - 48 hours after delivery of the placenta. Although the precise involvement of the placenta in pre-eclampsia remains unclear there are indications that the trophoblastic invasion of the uterine spiral arteries is abnormal in women who develop pre-eclampsia. This impaired invasion leads to decreased placental perfusion and ultimately to placental hypoxia. The distressed or ischaemic placenta then secretes a factor(s) into the maternal circulation, which cause/s widespread endothelial cell dysfunction characterized by vasospasm, activation of coagulation system and organ ischaemia. The cause of the defective cytotrophoblastic invasion of the spiral arteries and the link between placental ischaemia and generalized maternal endothelial dysfunction remain unknown. Although the placenta appears to have a major role in the pathogenesis of pre-eclampsia, evidence also suggests that factors like maternal genetic predisposition, dietary, environmental and behaviour, which surface during the stress of pregnancy might also be involved in the development of pre-eclampsia. It is known that not all women with poor cytotrophoblast invasion develop pre-eclampsia and not all women with preeclampsia show poor cytotrophoblast invasion. Over the years, a number of potential risk factors associated with the development of pre-eclampsia are being recognized and it might be appropriate now to develop some preventative strategies based upon the available information.

Entities:  

Keywords:  medical sciences; placenta; pre-eclampsia

Year:  2009        PMID: 22589643      PMCID: PMC3336172     

Source DB:  PubMed          Journal:  Malays J Med Sci        ISSN: 1394-195X


  80 in total

Review 1.  Review: immunobiology of preeclampsia.

Authors:  R N Taylor
Journal:  Am J Reprod Immunol       Date:  1997-01       Impact factor: 3.886

2.  CLINICAL OBSERVATIONS ON SOME ASPECTS OF HYDATIDIFORM MOLES.

Authors:  D CHUN; C BRAGA; C CHOW; L LOK
Journal:  J Obstet Gynaecol Br Commonw       Date:  1964-04

3.  Immunofluorescent study of placental bed vessels in pre-eclampsia of pregnancy.

Authors:  J L Kitzmiller; K Benirschke
Journal:  Am J Obstet Gynecol       Date:  1973-01-15       Impact factor: 8.661

4.  The relationship between abortion in the first pregnancy and development of pregnancy-induced hypertension in the subsequent pregnancy.

Authors:  D M Strickland; D S Guzick; K Cox; N F Gant; C R Rosenfeld
Journal:  Am J Obstet Gynecol       Date:  1986-01       Impact factor: 8.661

5.  Pre-eclampsia: more than pregnancy-induced hypertension.

Authors:  J M Roberts; C W Redman
Journal:  Lancet       Date:  1993-06-05       Impact factor: 79.321

Review 6.  Complications of assisted reproductive techniques.

Authors:  J G Schenker; Y Ezra
Journal:  Fertil Steril       Date:  1994-03       Impact factor: 7.329

7.  Morphological changes in the utero-placental bed in pregnancy hypertension.

Authors:  I A Brosens
Journal:  Clin Obstet Gynaecol       Date:  1977-12

8.  The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice.

Authors:  Fangxian Lu; Monica Longo; Esther Tamayo; William Maner; Ayman Al-Hendy; Garland D Anderson; Gary D V Hankins; George R Saade
Journal:  Am J Obstet Gynecol       Date:  2007-04       Impact factor: 8.661

9.  Preeclampsia related to a functioning extrauterine placenta: report of a case and 25-year follow-up.

Authors:  W F Piering; J G Garancis; C G Becker; J A Beres; J Lemann
Journal:  Am J Kidney Dis       Date:  1993-03       Impact factor: 8.860

10.  Sperm exposure and development of preeclampsia.

Authors:  Jon I Einarsson; Haleh Sangi-Haghpeykar; Michael O Gardner
Journal:  Am J Obstet Gynecol       Date:  2003-05       Impact factor: 8.661

View more
  4 in total

1.  Family history of chronic illness, preterm gestational age and smoking exposure before pregnancy increases the probability of preeclampsia in Omo district in southern Ethiopia: a case-control study.

Authors:  Kassahun Fikadu; Feleke G/Meskel; Firdawek Getahun; Nega Chufamo; Direslign Misiker
Journal:  Clin Hypertens       Date:  2020-08-15

2.  Evaluation of the PLAC8 Gene in Mexican Women With and Without Preeclampsia and Obesity.

Authors:  Laura Jazel Barragán-Zúñiga; Laurence A Marchat; Ivo Carrasco-Wong; Ricardo Blanco-Castaneda; José M Salas-Pacheco; Luis Ernesto Simental-Mendia; Miguel Mauricio Correa-Ramírez; Martha Sosa-Macías; Jaime Gutiérrez; Carlos Galaviz-Hernandez
Journal:  Front Med (Lausanne)       Date:  2022-02-17

3.  A Cross-Sectional Study Investigating the Association of Serum Iron Concentration and Platelet Count as a Risk Biomarker among the Pregnancy-Induced Hypertensive Women in the Highlands Western Ghats of Nilgiris.

Authors:  Roopa Satyanarayan Basutkar; Bhaktraj Singh Chauhan
Journal:  Indian J Community Med       Date:  2022-03-16

4.  Canonical, Non-Canonical and Atypical Pathways of Nuclear Factor кb Activation in Preeclampsia.

Authors:  Agata Sakowicz; Michalina Bralewska; Tadeusz Pietrucha; Dominika E Habrowska-Górczyńska; Agnieszka W Piastowska-Ciesielska; Agnieszka Gach; Magda Rybak-Krzyszkowska; Piotr J Witas; Hubert Huras; Mariusz Grzesiak; Lidia Biesiada
Journal:  Int J Mol Sci       Date:  2020-08-04       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.